Model‐based prediction of progression‐free survival for combination therapies in oncology

Progression‐free survival (PFS) is an important clinical metric for comparing and evaluating similar treatments for the same disease within oncology. After the completion of a clinical trial, a descriptive analysis of the patients' PFS is often performed post hoc using the Kaplan–Meier estimato...

Descripción completa

Detalles Bibliográficos
Autores principales: Baaz, Marcus, Cardilin, Tim, Jirstrand, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508530/
https://www.ncbi.nlm.nih.gov/pubmed/37300376
http://dx.doi.org/10.1002/psp4.13003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508530/
https://www.ncbi.nlm.nih.gov/pubmed/37300376
http://dx.doi.org/10.1002/psp4.13003

Ejemplares similares